Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

This study is designed to investigate long-term oncologic outcomes of single-incision laparoscopic surgery (SILS) compared to conventional laparoscopic surgery (CLS) for colorectal cancer.

Trial Details

NCT ID
NCT04527861
Phase
NA
Sponsor
Ruijin Hospital
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • Single-incision Laparoscopic Surgery
  • Conventional Laparoscopic Surgery
Locations (sample)
  • Lanzhou, Gansu, China|36.05701,103.83987
  • Shenyang, Liaoning, China|41.79222,123.43278
  • Shenyang, Liaoning, China|41.79222,123.43278
  • Jinan, Shandong, China|36.66833,116.99722
  • Chengdu, Sichuan, China|30.66667,104.06667

Key Eligibility Criteria

  • 18 years \< age ≤85 years
  • Tumor located in colon and high rectum ( the lower border of the tumor is above the peritoneal reflection)
  • Pathological or highly suspected colorectal carcinoma
  • Clinically diagnosed cT1-4aN0-2 M0 lesions according to the 8th Edition of AJCC Cancer Staging Manual

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →